Neuroprotective activities of catalpol on MPP+/MPTP-induced neurotoxicity

被引:25
作者
Jiang, Bo [1 ]
Zhang, Huang [1 ]
Bi, Jing [1 ]
Zhang, Xiu Li [1 ]
机构
[1] Dalian Univ Technol, Sch Environm & Biol Sci & Technol, Dalian 116024, Peoples R China
关键词
catalpol; Parkinson's disease; tyrosine hydroxylase; neurons; dopamine;
D O I
10.1179/174313208X289543
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Published by Maney Publishing (c) W. S. Maney & Son Limited Catalpol is an iridoid glycoside, distributed in the roots of Rehmannia glutinosa Libosch. In vitro results showed that preincubation with catalpol (0.5-0.5 mM) for 0.5 hours before and during 48 hour exposure to 0.2 mM MPP+ appeared to be significant protective effect while catalopl was considerably less effective at the doses of 0.001 to 0.01 mM. The addition of catalpol at the dose of 0.05-0.5 mM significantly increased DA and DOPAC to MPP+ treated group. C57bl/6 mice received administration of catalpol for 12 hours before and during the 7 day treatment with MPTP. Such treatment at doses of 15 mg/kg significantly and dramatically blocked tyrosine hydroxylase-positive cell loss in mice. DA turnover in MPTP mice was reversed in the nigrostriatal pathway. In conclusion, data obtained in the above study suggested that catalpol exerted neuroprotective action in vitro and in vivo PD model.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 26 条
[1]
Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach [J].
Bezard, E ;
Gross, CE .
PROGRESS IN NEUROBIOLOGY, 1998, 55 (02) :93-116
[2]
Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse [J].
Bezard, E ;
Jaber, M ;
Gonon, F ;
Boireau, A ;
Bloch, B ;
Gross, CE .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (08) :2892-2900
[3]
Camicioli R, 2001, MOVEMENT DISORD, V16, P33, DOI 10.1002/1531-8257(200101)16:1<33::AID-MDS1014>3.0.CO
[4]
2-W
[5]
An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration [J].
Cassarino, DS ;
Bennett, JP .
BRAIN RESEARCH REVIEWS, 1999, 29 (01) :1-25
[6]
Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor [J].
Choi-Lundberg, DL ;
Lin, Q ;
Schallert, T ;
Crippens, D ;
Davidson, BL ;
Chang, YN ;
Chiang, YWL ;
Qian, JA ;
Bardwaj, L ;
Bohn, MC .
EXPERIMENTAL NEUROLOGY, 1998, 154 (02) :261-275
[7]
Description of Parkinson's disease as a clinical syndrome [J].
Fahn, S .
PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 :1-14
[8]
MELANIZED DOPAMINERGIC-NEURONS ARE DIFFERENTIALLY SUSCEPTIBLE TO DEGENERATION IN PARKINSONS-DISEASE [J].
HIRSCH, E ;
GRAYBIEL, AM ;
AGID, YA .
NATURE, 1988, 334 (6180) :345-348
[9]
Hirsch EC, 2000, FUNCT NEUROL, V15, P229
[10]
Levodopa strengths and weaknesses [J].
Jankovic, J .
NEUROLOGY, 2002, 58 (04) :S19-S32